Collegium Pharmaceutical: Q4 Earnings Snapshot

In this article:

STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported fourth-quarter profit of $31.9 million.

On a per-share basis, the Stoughton, Massachusetts-based company said it had profit of 82 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.58 per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.33 per share.

The specialty pharmaceutical company posted revenue of $149.7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $147.7 million.

For the year, the company reported profit of $48.2 million, or $1.29 per share. Revenue was reported as $566.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL

Advertisement